Log in to save to my catalogue

Design of the RELAXin in Acute Heart Failure Study

Design of the RELAXin in Acute Heart Failure Study

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_920230593

Design of the RELAXin in Acute Heart Failure Study

About this item

Full title

Design of the RELAXin in Acute Heart Failure Study

Publisher

New York, NY: Mosby, Inc

Journal title

The American heart journal, 2012-02, Vol.163 (2), p.149-155.e1

Language

English

Formats

Publication information

Publisher

New York, NY: Mosby, Inc

More information

Scope and Contents

Contents

Background Acute heart failure (AHF) remains a major public health burden with a high prevalence and poor prognosis. Relaxin is a naturally occurring peptide hormone that increases cardiac output, arterial compliance, and renal blood flow during pregnancy. The RELAX-AHF-1 study will evaluate the effect of RLX030 (recombinant form of human relaxin 2...

Alternative Titles

Full title

Design of the RELAXin in Acute Heart Failure Study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_920230593

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_920230593

Other Identifiers

ISSN

0002-8703

E-ISSN

1097-6744

DOI

10.1016/j.ahj.2011.10.009

How to access this item